米国臨床内分泌学者協会およびアメリカ内分泌大学内分泌学会臨床診療ガイドライン後、閉経後骨粗鬆症の診断と治療のためのガイドライン-2016-執行要約

AACE =アメリカ臨床内分泌学者協会aff =非定型大腿骨骨折ASBMR =アメリカ骨および鉱物研究協会BEL =ベストエビデンスレベルBMD =骨ミネラル密度BTM =骨代謝回転マーカーCBCX線吸収測定EL =エビデンスレベルFDA =米国食品および医薬品局のFLEX =骨折介入試験（FIT）長期拡張FRAX（®）=骨折リスク評価ツールGFR =糸球体ろ過率GI =胃腸水平=健康上の結果と減少毎年1回のゾレドロン酸による発生率IOF =国際骨粗鬆症基礎ISCD =国際臨床濃度測定協会IU =国際単位IV =静脈内LSC =最小有意な変化NBHA =国立骨骨健康同盟NOF =国立骨粗鬆症基礎25（OH）D = 25-ヒドロシシビタミンD ONJ =顎の骨壊死pinp = I型コラーゲンの血清カルボキシ末端プロペププチドPTH =副甲状腺ホルモンr =推奨ランク=核因子Kappa-B rankl =核因子Kappa-BリガンドRCTの受容体活性化因子=ランダム化されたランダム化制御された試験RR =相対リスクS-CTX =血清C末端テルペプチドSq =皮下VFA =椎骨骨折評価who =世界保健機関。

AACE = American Association of Clinical Endocrinologists AFF = atypical femur fracture ASBMR = American Society for Bone and Mineral Research BEL = best evidence level BMD = bone mineral density BTM = bone turnover marker CBC = complete blood count CI = confidence interval DXA = dual-energy X-ray absorptiometry EL = evidence level FDA = U.S. Food and Drug Administration FLEX = Fracture Intervention Trial (FIT) Long-term Extension FRAX(®) = Fracture Risk Assessment Tool GFR = glomerular filtration rate GI = gastrointestinal HORIZON = Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly IOF = International Osteoporosis Foundation ISCD = International Society for Clinical Densitometry IU = international units IV = intravenous LSC = least significant change NBHA = National Bone Health Alliance NOF = National Osteoporosis Foundation 25(OH)D = 25-hydroxy vitamin D ONJ = osteonecrosis of the jaw PINP = serum carboxy-terminal propeptide of type I collagen PTH = parathyroid hormone R = recommendation RANK = receptor activator of nuclear factor kappa-B RANKL = receptor activator of nuclear factor kappa-B ligand RCT = randomized controlled trial RR = relative risk S-CTX = serum C-terminal telopeptide SQ = subcutaneous VFA = vertebral fracture assessment WHO = World Health Organization.